Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...
AstraZeneca and the Memorial Sloan Kettering Cancer Center (MSK) have tapped digital health tech company IgniteData to ...
Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...
Medical Device Network on MSN1d
City of Hope and MSK develop tool to predict CAR T therapy outcomes for NHLResearchers from the City of Hope and Memorial Sloan Kettering (MSK) Cancer Center, US, have developed a tool named ...
New York City-based Memorial Sloan Kettering Cancer Center plans to implement Abridge’s AI platform across its system in 2025 and 2026. The platform transcribes medical conversations into real ...
This is the 11th year that Little Eric’s Foundation participated, as an organization, in Cycle for Survival in New York City.
Actinium Pharmaceuticals (ATNM) has entered into a sponsored research agreement with Memorial Sloan Kettering Cancer Center to expand ...
HealthDay on MSN5d
Pelabresib Plus Ruxolitinib Improves Underlying MyelofibrosisPelabresib, a bromodomain and extraterminal domain inhibitor, plus ruxolitinib (a Janus kinase [JAK] inhibitor) improves ...
IgniteData is committed to scaling its EHR-to-EDC automation across global research sites, further advancing clinical trial innovation. Insights gained from each deployment will continue to refine and ...
Actinium Pharma inks research pact with Memorial Sloan Kettering to support further clinical expansion of Actimab-A's backbone therapy strategy: New York Saturday, March 22, 2025, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback